Cargando…

Psychometric evaluation of the Indolent Systemic Mastocytosis Symptom Assessment Form (ISM-SAF(©)) and determination of a threshold score for moderate symptoms

BACKGROUND: The Indolent Systemic Mastocytosis Symptom Assessment Form (ISM-SAF) (©Blueprint Medicines Corporation), a 12-item daily diary that assesses 11 signs and symptoms of indolent systemic mastocytosis (ISM) and smoldering systemic mastocytosis (SSM), was psychometrically evaluated among pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shields, Alan L., Taylor, Fiona, Lamoureux, Roger E., Padilla, Brad, Severson, Kas, Green, Tanya, Boral, Anthony L., Akin, Cem, Siebenhaar, Frank, Mar, Brenton
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039595/ https://www.ncbi.nlm.nih.gov/pubmed/36964624 http://dx.doi.org/10.1186/s13023-023-02661-1

Ejemplares similares

Development of symptom-focused outcome measures for advanced and indolent systemic mastocytosis: the AdvSM-SAF and ISM-SAF(©)
por: Taylor, Fiona, et al.
Publicado: (2021)

Psychometric evaluation of the Indolent Systemic Mastocytosis Symptom Assessment Form (ISM-SAF) in a phase 2 clinical study
por: Padilla, Brad, et al.
Publicado: (2021)

The Number of MRGPRX2-Expressing Cells Is Increased in Skin Lesions of Patients With Indolent Systemic Mastocytosis, But Is Not Linked to Symptom Severity
por: Pyatilova, Polina, et al.
Publicado: (2022)

Efficacy of Omalizumab in Indolent Systemic Mastocytosis
por: Slapnicar, Calum, et al.
Publicado: (2019)

Treatment of Indolent and Advanced Systemic Mastocytosis
por: Buonomo, Alessandro, et al.
Publicado: (2022)

Indolent systemic mastocytosis in a patient with ileocolitis
por: Chrysakopoulos, Georgios, et al.
Publicado: (2014)

Delayed Diagnosis of Adult Indolent Systemic Mastocytosis
por: Mikkelsen, Carsten Sauer, et al.
Publicado: (2014)

Indolent systemic mastocytosis mimicking Crohn’s disease
por: Hadjivasilis, Alexandros, et al.
Publicado: (2019)

Mediator-Related Symptoms and Anaphylaxis in Children with Mastocytosis
por: Brockow, Knut, et al.
Publicado: (2021)

Clinical presentation and markers of cutaneous versus systemic mastocytosis: the mastocytosis center at brigham and women's hospital in Boston
por: Kanamori, Kelly Yoshimi, et al.
Publicado: (2015)

Indolent Systemic Mastocytosis Manifesting as Protracted Anaphylactic Shock
por: Chatterjee, Manidipam, et al.
Publicado: (2018)

Primary cicatricial alopecia associated with systemic indolent mastocytosis
por: Prasad, Sonya, et al.
Publicado: (2020)

DNA methylation profile in patients with indolent systemic mastocytosis
por: Górska, Aleksandra, et al.
Publicado: (2021)

P1017: REDUCTIONS IN INDOLENT SYSTEMIC MASTOCYTOSIS BIOMARKER BURDEN WITH AVAPRITINIB IN THE REGISTRATIONAL, DOUBLE-BLIND PLACEBO-CONTROLLED PIONEER TRIAL
por: Gotlib, Jason, et al.
Publicado: (2023)

Indolent systemic mastocytosis associated with light chain deposition disease
por: Sasaki, Kotaro, et al.
Publicado: (2012)

Diagnosis of indolent systemic mastocytosis in a patient with “seborrheic keratosis”
por: Moshref Razavi, Habib, et al.
Publicado: (2022)

Myeloproliferative Neoplasm Symptom Assessment Form - Total Symptom Score (MPN-SAF TSS) questionnaire: translation, cultural adaptation and validation to Brazilian Portuguese
por: Guaraná, Mariana, et al.
Publicado: (2022)

COVID-19 infection in patients with mast cell disorders including mastocytosis does not impact mast cell activation symptoms
por: Giannetti, Matthew P., et al.
Publicado: (2021)

The role of the clinical and psychological symptoms of mastocytosis in the patient’s quality of life
por: Spolak-Bobryk, Natalia, et al.
Publicado: (2021)

Safety of COVID-19 vaccination in patients with mastocytosis and monoclonal mast cell activation syndrome
por: Kaakati, Rayan, et al.
Publicado: (2021)

Venom immunotherapy in indolent systemic mastocytosis with high serum tryptase level
por: Selcuk, Ali, et al.
Publicado: (2021)

Ruxolitinib improves symptoms and quality of life in a patient with systemic mastocytosis
por: Yacoub, Abdulraheem, et al.
Publicado: (2016)

Multidisciplinary Challenges in Mastocytosis and How to Address with Personalized Medicine Approaches
por: Valent, Peter, et al.
Publicado: (2019)

COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM)
por: Bonadonna, Patrizia, et al.
Publicado: (2021)

The SAF-box domain of chromatin protein DEK
por: Böhm, Friederike, et al.
Publicado: (2005)

Pancreatic neuroendocrine tumor presenting in indolent systemic mastocytosis: A case report
por: Sacco, Keith, et al.
Publicado: (2020)

Genome-Wide DNA Methylation and Gene Expression in Patients with Indolent Systemic Mastocytosis
por: Górska, Aleksandra, et al.
Publicado: (2023)

Black Looks ... at 'Isms'
por: Black, Douglas
Publicado: (1992)

Buffalo as an ISM Center
Publicado: (1900)

simpleISM—A straight forward guide to upgrade from confocal to ISM
por: Goswami, Monalisa, et al.
Publicado: (2022)

Cutaneous and Gastrointestinal Symptoms in Two Patients with Systemic Mastocytosis Successfully Treated with Omalizumab
por: Lieberoth, Sofie, et al.
Publicado: (2015)

Serum Tryptase Monitoring in Indolent Systemic Mastocytosis: Association with Disease Features and Patient Outcome
por: Matito, Almudena, et al.
Publicado: (2013)

Self-adjusting file (SAF) separation in clinical use: A preliminary survey among experienced SAF users regarding prevalence and retrieval methods
por: Solomonov, Michael, et al.
Publicado: (2015)

Complete Genome Sequence of Microbacterium sp. Strain Nx66, Isolated from Waters Contaminated with Petrochemicals in El Saf-Saf Valley, Algeria
por: Chéraiti, Nardjess, et al.
Publicado: (2020)

P1017: HARBOR: A PHASE 2/3 STUDY OF BLU-263 IN PATIENTS WITH INDOLENT SYSTEMIC MASTOCYTOSIS AND MONOCLONAL MAST CELL ACTIVATION SYNDROME
por: Castells, M., et al.
Publicado: (2022)

Modern Isms and Ologies, (Poetical)
Publicado: (1874)

The Cure of Cancer by Mattei-ism
por: Boncher, M. Louis
Publicado: (1892)

A Third “Ism”: Ageism
por: DeMaria, Anthony
Publicado: (2023)

Preclinical human models and emerging therapeutics for advanced systemic mastocytosis
por: Arock, Michel, et al.
Publicado: (2018)

How persons with systemic mastocytosis describe the time between symptom onset and receiving diagnosis
por: Hamberg Levedahl, Kerstin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_oddlj7gll504fesm0jldj8rskr